Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01289574 · ClinicalTrials.gov registry record · Phase 2
Topical ASC-J9 Cream for Acne
A Phase 2 study, sponsored by AndroScience.
- Completed
- Registry status
- Phase 2
- Development phase
- 181
- Enrollment target
NCT01289574 is a Phase 2 study that has completed, run by AndroScience. The registered enrollment target is 181 participants.
The verdict
NCT01289574, a Phase 2 study, has completed, sponsored by AndroScience.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 181 participants
- Enrollment target
Study Summary
To evaluate the safety and efficacy of topical 0.1% and 0.025% ASC-J9 creams applied twice daily for facial acne compared to vehicle control.
Interventions
- DRUG ASC-J9
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 181 participants |
| Start Date | 2011-02 |
| Est. Completion | 2012-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01289574
The ClinicalTrials.gov registry entry for NCT01289574 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 181 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AndroScience, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ASC-J9 is the first listed.
NCT01289574 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01289574 about?
NCT01289574 is a clinical study titled "Topical ASC-J9 Cream for Acne". To evaluate the safety and efficacy of topical 0.1% and 0.025% ASC-J9 creams applied twice daily for facial acne compared to vehicle control.
What is the current status of trial NCT01289574?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 181 participants. The study started on 2011-02. Estimated completion is 2012-08.
What interventions are being tested in trial NCT01289574?
The interventions under investigation include: ASC-J9 (DRUG).
Who is sponsoring clinical trial NCT01289574?
This trial is sponsored by AndroScience, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.